-
Yutaka SHIMIZU
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Mochida Pharmaceutical Co., Ltd., Medical Affairs
-
Ryotaro SONODA
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Mitsubishi Tanabe Pharma Corporation, Ikuyaku. Integrated Value Development Division Medical Affairs Department
-
Kosaku FUJIWARA
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Daiichi Sankyo Co., Ltd., Oncology Medical Science Department, Medical Affairs Division
-
Takeshi NISHIMURA
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Sumitomo Pharma Co., Ltd., Clinical Research, Drug Development Division
-
Seiji HOASHI
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Chugai Pharmaceutical Co., Ltd., Medical Affairs Div.
-
Naoki INOUE
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Nippon Shinyaku Co., LTD., Medical Affairs Division.
-
Kohji MURAKAMI
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Nippon Shinyaku Co., LTD., Medical Affairs Division.
-
Nobuyuki TANAKA
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Novo Nordisk Pharma Ltd., Medical Affairs Department
-
Atsushi KANEKO
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Biogen Japan Ltd., Medical
-
Tetsuya SHIINA
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Abbvie GK Medical
-
Etsuko YAMASAKI
Japan Pharmaceutical Manufacturers Association （JPMA）, Drug Evaluation Committee Merck Biopharma Co., Ltd., Medical department
